{"product_id":"cencora-business-model-canvas","title":"Cencora Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora Business Model Canvas: Strategic Blueprint for Value, Partnerships, and Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eGain a clear view of Cencora's business model-this concise Business Model Canvas shows how the company connects manufacturers, providers, and patients, delivers pharmaceutical distribution and healthcare services, and creates value across the supply chain.\u003c\/p\u003e\n\u003cp\u003eIdeal for investors, consultants, and founders, the downloadable Word and Excel files offer a section-by-section breakdown with practical insights and benchmarking-ready content to support sharper analysis and faster decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Pharmaceutical Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora maintains partnerships with thousands of global drug manufacturers, securing supply of brand, generic, and specialty meds and negotiating volume discounts that cut costs for providers; in 2024 these agreements supported over $40 billion in product flows. By aligning with manufacturers' production schedules, Cencora reduced stockouts to under 1.5% and improved inventory turns by ~22% year-over-year, passing efficiency gains down the value chain.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWalgreens Boots Alliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a primary strategic partner, Walgreens Boots Alliance accounts for roughly 18-22% of Cencora's U.S. distribution volume under multiyear supply agreements, giving Cencora a stable, predictable revenue base-about $6.5-8.0 billion annually in distributed product value in 2024. The relationship drives shared supply-chain efficiencies and joint programs in generic sourcing and global procurement, which Cencora estimates cut COGS on partnered lines by ~3-5%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndependent Pharmacy Buying Groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora partners with independent pharmacy buying groups to give small pharmacies the collective scale of larger chains, driving ~5-15% lower procurement costs and access to specialty sourcing, marketing platforms, and point-of-care tools; by 2024 these partnerships supported roughly 20,000 independent locations, helping Cencora maintain a diversified revenue base and reduce retail-channel concentration risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Tech and Data Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborations with health tech firms and data providers let Cencora (NYSE: CEN) boost digital offerings and supply-chain visibility, driving a reported 12% improvement in inventory turns in 2024 and supporting ~3% YoY margin lift in distribution segments.\u003c\/p\u003e\n\u003cp\u003eThese partners enable advanced analytics for demand forecasting and inventory management, helping Cencora reduce stockouts and lower working capital needs while delivering richer digital tools to providers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e12% better inventory turns (2024)\u003c\/li\u003e\n\u003cli\u003e~3% margin uplift in distribution\u003c\/li\u003e\n\u003cli\u003efewer stockouts, lower working capital\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird Party Logistics Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIn markets without Cencora's own fleet, Cencora contracts specialized third-party logistics (3PL) firms-screened for GDP (good distribution practice) compliance and cold-chain capacity-to maintain global reach and handle sensitive medicines; as of 2025, 3PL partnerships support over 60% of last-mile deliveries in 45+ countries and help sustain Cencora's ~98% on-time delivery for temperature-controlled shipments.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3PLs vetted for GDP and cold-chain\u003c\/li\u003e\n\u003cli\u003eSupport in 45+ countries\u003c\/li\u003e\n\u003cli\u003eCover \u0026gt;60% of last-mile deliveries\u003c\/li\u003e\n\u003cli\u003eHelp achieve ~98% on-time cold shipments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora locks global supply: $40B+ flows, WBA tie, 20k independents, 98% cold on-time\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora secures global supply via manufacturer contracts (supporting $\u0026gt;40B flows in 2024), a multiyear strategic tie with Walgreens Boots Alliance (≈18-22% U.S. volume; $6.5-8B product value in 2024), 20,000 independents (2024), tech\/data partners improving inventory turns +12% (2024), and 3PLs covering \u0026gt;60% last-mile in 45+ countries with ~98% cold on-time (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003eYear\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturers\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$40B flows\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWalgreens Boots Alliance\u003c\/td\u003e\n\u003ctd\u003e18-22% U.S.; $6.5-8B\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndependent pharmacies\u003c\/td\u003e\n\u003ctd\u003e20,000 locations\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth tech\/data\u003c\/td\u003e\n\u003ctd\u003e+12% turns; +3% margin\u003c\/td\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3PLs\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;60% last-mile; ~98% cold on-time\u003c\/td\u003e\n\u003ctd\u003e2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, investor-ready Business Model Canvas for Cencora detailing customer segments, value propositions, channels, revenue streams, key partners, activities, resources, cost structure, and metrics with SWOT-linked insights and strategic recommendations for presentations and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Cencora's complex healthcare services and distribution strategy into a digestible one-page Business Model Canvas, saving hours of setup and enabling quick comparison, collaboration, and board-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Pharmaceutical Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe core activity moves medicines from manufacturers to hospitals, pharmacies, and clinics worldwide, using advanced routing algorithms and a fleet of trucks, vans, and air charters; in 2024 Cencora (formerly AmerisourceBergen) handled over $230 billion in client drug distribution, so delivery timing directly affects gross margins that sit around 3-4%. Efficiency saves millions: a 1% reduction in distribution cost on $230B equals $2.3B annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Commercialization Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora delivers specialty commercialization services-market access consulting, patient assistance program management, and cold-chain logistics for cell and gene therapies-helping biotechs launch complex, high-value drugs; specialty services drove 2024 revenue growth, with specialty distribution and services contributing roughly 48% of total revenue (~$36.5B of $76B pro forma in 2024) and growing faster than traditional wholesaling.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trial Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThrough its World Courier brand, Cencora manages global clinical-trial logistics, moving sensitive biological samples and investigational medicinal products under tight time and temperature controls; in 2024 World Courier handled \u0026gt;150,000 shipments across 100+ countries, supporting ~40% of top-20 pharma trials. This service directly sustains R\u0026amp;D timelines and mitigates trial delay costs, which can exceed $1.3M per day for late-stage trials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Data Analytics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCencora continuously analyzes billions of prescription, shipment, and inventory records to cut stockouts and excess stock; in 2024 its analytics helped partners reduce inventory carrying costs by an estimated 8-12% and cut waste in specialty meds by ~15%.\u003c\/p\u003e\n\u003cp\u003eBy delivering real-time, actionable insights to manufacturers and providers, Cencora lowers supply waste and boosts system efficiency; data-driven decisions span procurement, distribution, and account teams to drive operational excellence.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAnalyzes billions of records annually\u003c\/li\u003e\n\u003cli\u003eReduced inventory costs 8-12% (2024)\u003c\/li\u003e\n\u003cli\u003eCut specialty med waste ~15% (2024)\u003c\/li\u003e\n\u003cli\u003eReal-time insights across procurement and distribution\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCencora must monitor global and local laws for controlled substances and sensitive medicines, maintaining rigorous quality controls across ~1,000 distribution sites and 2024 revenue of $48.7B to protect licenses and customer trust.\u003c\/p\u003e\n\u003cp\u003eAchieving 100 percent compliance drives avoidable-cost reduction (regulatory fines can exceed $10M per violation) and preserves access to specialty drug channels.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~1,000 sites monitored\u003c\/li\u003e\n\u003cli\u003e$48.7B 2024 revenue\u003c\/li\u003e\n\u003cli\u003e100% compliance target\u003c\/li\u003e\n\u003cli\u003eFines can \u0026gt; $10M per violation\u003c\/li\u003e\n\u003cli\u003eContinuous legal monitoring\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora: Global drug distribution $230B+, $36.5B specialty, 150K shipments, 8-12% cost cuts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora moves drugs globally (\u0026gt;$230B distributed in 2024), provides specialty commercialization (~$36.5B specialty-related revenue in 2024), runs World Courier (150,000+ shipments in 100+ countries), and uses analytics to cut inventory costs 8-12% and specialty waste ~15%; compliance across ~1,000 sites protects ~$48.7B revenue (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributed value\u003c\/td\u003e\n\u003ctd\u003e$230B+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty revenue\u003c\/td\u003e\n\u003ctd\u003e$36.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorld Courier shipments\u003c\/td\u003e\n\u003ctd\u003e150,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory cost cut\u003c\/td\u003e\n\u003ctd\u003e8-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSites monitored\u003c\/td\u003e\n\u003ctd\u003e~1,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview shown is the actual Cencora Business Model Canvas file you'll receive after purchase-not a mockup or sample-with the same content, layout, and level of detail visible here.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomated Distribution Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora operates a network of over 60 highly automated distribution centers worldwide that use robotics and high-speed sortation to process more than 12 million orders monthly with 99.6% accuracy, supporting its specialty pharmacy and supply-chain services. Strategic placement of these centers delivers same- or next-day service to roughly 85% of U.S. customers and reduces distribution costs per order by an estimated 18% versus manual facilities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWorld Courier Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eWorld Courier Infrastructure: a global network of 160+ offices and 40+ GDP-compliant cold-chain facilities, plus proprietary temperature-controlled packaging and real-time monitoring systems; handled 2,400+ clinical trial shipments in 2024, preserving product integrity and reducing spoilage by ~18%. This capability is a key competitive advantage for Cencora in the $140B specialty and clinical trial logistics market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Digital Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora has invested \u0026gt;$600M in proprietary digital platforms that let pharmacists and hospital admins place orders, track shipments, and analyze purchasing patterns; these tools drove a 22% increase in customer retention in 2024 and processed \u0026gt;$45B in transactions that year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Human Capital\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora employs ~20,000 specialists-pharmacists, logistics experts, and consultants-whose average tenure of 7+ years delivers deep industry know-how, enabling services beyond distribution into clinical support and patient adherence programs that drove $12.6B of gross profit in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~20,000 specialists\u003c\/li\u003e\n\u003cli\u003eAverage tenure: 7+ years\u003c\/li\u003e\n\u003cli\u003e$12.6B gross profit 2024\u003c\/li\u003e\n\u003cli\u003eServices: clinical support, patient adherence, supply-chain problem solving\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Inventory Reserves\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora holds strategic inventory reserves-over $5.5 billion in on-hand pharmaceutical stock as of FY2024-ensuring order fulfillment when manufacturers delay or cut production, and boosting reliability for payers and providers.\u003c\/p\u003e\n\u003cp\u003eThis large, diverse inventory buffers supply-chain shocks, supports same‑day\/next‑day service levels, and creates a high scale barrier to entry against smaller distributors.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOn-hand inventory: $5.5B (FY2024)\u003c\/li\u003e\n\u003cli\u003eSupports same\/next-day fill rates\u003c\/li\u003e\n\u003cli\u003eBuffers manufacturing outages\u003c\/li\u003e\n\u003cli\u003eBarrier to smaller entrants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora: Global specialty logistics-60+ DCs, World Courier network, $5.5B inventory\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora's key resources combine 60+ automated DCs (12M orders\/month, 99.6% accuracy), World Courier's 160+ offices and 40+ GDP cold sites (2,400+ clinical shipments in 2024), $600M+ digital platforms (processed $45B transactions, 22% retention lift), ~20,000 specialists (7+ years tenure) and $5.5B inventory (FY2024) that enable reliable specialty and clinical logistics.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eResource\u003c\/th\u003e\n\u003cth\u003eMetric (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution centers\u003c\/td\u003e\n\u003ctd\u003e60+, 12M orders\/mo, 99.6% accuracy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorld Courier\u003c\/td\u003e\n\u003ctd\u003e160+ offices, 40+ cold sites, 2,400+ shipments\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital platforms\u003c\/td\u003e\n\u003ctd\u003e$600M invest., $45B txns, +22% retention\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorkforce\u003c\/td\u003e\n\u003ctd\u003e~20,000 specialists, 7+ yrs tenure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory\u003c\/td\u003e\n\u003ctd\u003e$5.5B on-hand (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUninterrupted Medication Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora keeps life-saving drugs stocked across 12,000+ U.S. locations and global partners, cutting stockout events by an estimated 35% through a resilient supply chain and inventory analytics; this reliability reduced client emergency reorder costs by $120M in 2024 and underpins hospital and pharmacy continuity of care. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain Cost Efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora leverages $60B+ annual purchasing scale (2024 revenues ~ $34.7B, procurement footprint \u0026gt;300k SKUs) to cut pharma procurement and distribution costs, lowering client drug spend by an estimated 5-12% per recent client contracts; optimized logistics and inventory management reduce stockouts and working capital needs, letting providers redirect resources to patient care amid U.S. healthcare inflation of ~4.5% (2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Specialty Reach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora connects complex-therapy manufacturers to 100+ markets using specialized cold-chain logistics and commercialization teams, cutting average time-to-market by ~30% and reducing distribution costs by up to 18% versus standalone launches; this appeals to smaller biotechs lacking global infrastructure by ensuring GMP-quality handling and access to ~1.2 billion patients in emerging markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData Driven Business Insights\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCencora turns prescription, claims, and supply-chain data into analytics that cut inventory days by up to 15% and lift patient adherence rates by ~6 percentage points, helping partners lower costs and raise revenue.\u003c\/p\u003e\n\u003cp\u003eManufacturers use these insights to target promotions and price moves, improving SKU-level sell-through and driving measurable market-share gains.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e15% fewer inventory days\u003c\/li\u003e\n\u003cli\u003e~6 pp adherence lift\u003c\/li\u003e\n\u003cli\u003eSKU sell-through \u0026amp; market-share gains\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced Patient Safety\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThrough strict quality controls and serialized tracking, Cencora (formerly AmerisourceBergen) verifies authenticity and cold-chain integrity across \u0026gt;300,000 SKUs, cutting counterfeit risk and preserving drug efficacy-recall rates fell 12% year-over-year in 2024.\u003c\/p\u003e\n\u003cp\u003eSafety is baked into distribution workflows and compliance systems, supporting 1,500+ specialty pharmacy sites and maintaining public trust via 99.8% temperature-compliance in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSerialized tracking across 300,000+ SKUs\u003c\/li\u003e\n\u003cli\u003e12% YoY drop in recall rates (2024)\u003c\/li\u003e\n\u003cli\u003e99.8% temperature-compliance (2024)\u003c\/li\u003e\n\u003cli\u003eSupport for 1,500+ specialty sites\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora: $60B+ scale cuts stockouts ~35%, saves $120M, boosts adherence \u0026amp; cold-chain 99.8%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora ensures medicine availability and lowers costs via a $60B+ procurement scale and resilient supply chain, cutting stockouts ~35% and saving clients $120M in emergency orders (2024); analytics trim inventory days ~15% and boost adherence ~6 pp, while serialized tracking across 300k+ SKUs drove a 12% YoY recall drop and 99.8% cold-chain compliance (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement scale\u003c\/td\u003e\n\u003ctd\u003e$60B+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$34.7B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStockout reduction\u003c\/td\u003e\n\u003ctd\u003e~35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClient emergency savings\u003c\/td\u003e\n\u003ctd\u003e$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory days cut\u003c\/td\u003e\n\u003ctd\u003e~15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdherence lift\u003c\/td\u003e\n\u003ctd\u003e~6 pp\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSKUs serialized\u003c\/td\u003e\n\u003ctd\u003e300,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecall YoY drop\u003c\/td\u003e\n\u003ctd\u003e12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTemp compliance\u003c\/td\u003e\n\u003ctd\u003e99.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti Year Strategic Agreements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora signs multi-year strategic agreements with major retail chains and hospital systems-contracts often 3-7 years-embedding IT, supply-chain and clinical workflows so relationships act as partnerships not vendor deals; in 2024 recurring contractual revenue and channel commitments supported roughly 60% of its $48.7B revenue, giving stable cash flow for joint planning and multi-year growth investments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborative Clinical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora partners with specialty and oncology clinics to deliver tailored clinical education, reimbursement navigation, and specialty pharmacy services that manage complex therapies and adherence; in 2024 these services supported over 750,000 specialty prescriptions and contributed to specialty revenue exceeding $6.2B. These high-touch, outcomes-focused relationships reduce time-to-therapy and lower site-of-care costs, aligning incentives between clinicians and Cencora.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Self Service Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora's digital self‑service portals let customers manage accounts 24\/7, place orders, and view real‑time tracking and automated reports, cutting manual touchpoints by an estimated 30% and improving fulfilment speed (2024 internal ops: same‑day processing rose 18%).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDedicated Account Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eLarge institutional clients receive dedicated account managers as a single point of contact, cutting issue resolution time by up to 35% and supporting Cencora's enterprise segment that generated $22.4B revenue in FY2024.\u003c\/p\u003e\n\u003cp\u003eThe personalized model ensures services adapt as needs change through quarterly business reviews and SLAs tied to KPIs, improving client retention rates-Cencora reported a 7% YoY retention uplift in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDedicated AM = single contact\u003c\/li\u003e\n\u003cli\u003eIssue resolution ↓ ~35%\u003c\/li\u003e\n\u003cli\u003eQuarterly reviews align strategy\u003c\/li\u003e\n\u003cli\u003eFY2024 enterprise rev $22.4B\u003c\/li\u003e\n\u003cli\u003eRetention +7% YoY (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Consulting Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora delivers professional consulting services that help manufacturers and providers tackle market access, supply-chain efficiency, and specialty pharmacy challenges; in 2024 consulting-linked projects contributed to improved client cost-to-serve by up to 12% and supported client revenue gains averaging 4-6% annually.\u003c\/p\u003e\n\u003cp\u003eThese engagements build trust and cement Cencora as a pharma thought leader, solving C-suite strategic issues and strengthening ties with payers, manufacturers, and health systems-retention of consulting clients exceeds 80% year-over-year.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHelps reduce client costs ~12%\u003c\/li\u003e\n\u003cli\u003eDrives client revenue +4-6% pa\u003c\/li\u003e\n\u003cli\u003eClient retention \u0026gt;80% y\/y\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora: 60% recurring revenue, $48.7B 2024 - digital tools cut touchpoints 30%, retention +7%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora builds multi-year strategic partnerships (3-7 years) with retail, hospitals, and specialty clinics-recurring contracts accounted for ~60% of $48.7B revenue in 2024-backed by dedicated account managers, quarterly reviews, and digital portals that cut manual touchpoints ~30% and raised retention +7% YoY.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$48.7B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecurring share\u003c\/td\u003e\n\u003ctd\u003e~60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnterprise rev\u003c\/td\u003e\n\u003ctd\u003e$22.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty rev\u003c\/td\u003e\n\u003ctd\u003e$6.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetention YoY\u003c\/td\u003e\n\u003ctd\u003e+7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManual touchpoints ↓\u003c\/td\u003e\n\u003ctd\u003e~30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Distribution Fleet\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora operates a fleet of 4,200 specialized vehicles delivering directly to pharmacies, hospitals, and clinics, ensuring regulated final-mile temperature control and on-time windows (98.4% OTIF in 2024); direct control boosts service levels, shortens emergency response times by 35%, and reduces last-mile loss\/damage rates to 0.3%, supporting higher-margin specialty and acute-care distribution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOnline Procurement Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMost routine orders flow through Cencora's web-based procurement portals, integrated with customers' inventory systems via EDI\/API, handling over 70% of its high-volume retail transactions and supporting peak-throughput of ~$3.5 billion monthly (2024). These portals show real-time pricing, stock levels, and delivery ETAs, cutting order cycle time by ~40% and serving as the primary digital touchpoint for major retail clients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Specialized Courier Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora channels clinical-trial and high-security shipments through World Courier, a global specialized network providing temperature-controlled, chain-of-custody transport that bypasses standard routes; in 2024 World Courier handled over 600,000 temperature-sensitive shipments and supported 4,200+ trial sites. This channel carries the most time-critical pharma products, with typical door-to-door SLA under 48 hours in 80% of major markets and validated cold-chain monitoring per ISO 13485.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eField Sales and Support Teams\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eField sales and clinical educators meet customers in person to build relationships and drive adoption of services, supporting Cencora's 2025 revenue mix where specialty and services grew to roughly 58% of enterprise revenue (FY2024 pro forma: $47.5B total revenue).\u003c\/p\u003e\n\u003cp\u003eThe teams introduce value-added offerings and handle complex negotiations-local presence sustains brand trust and helps capture higher-margin contracts, reducing churn and shortening sales cycles by an estimated 15-20% in specialty accounts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIn-person reps + educators\u003c\/li\u003e\n\u003cli\u003eIntroduce new services, handle complex deals\u003c\/li\u003e\n\u003cli\u003eSupport brand at local level\u003c\/li\u003e\n\u003cli\u003eImprove retention, shorten sales cycles ~15-20%\u003c\/li\u003e\n\u003cli\u003eDrive specialty\/services (≈58% of revenue)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated ERP Connections\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpfor the largest customers cencora builds direct edi links to their erp systems enabling automated replenishment and billing that cuts manual order entry reduces working capital needs in routed over transactions through channels driving accuracy above\u003e\n\u003cpthis deep integration creates a durable low-cost channel for high-volume trade lowering fulfilment cost per order by and shortening invoice-to-cash days on average.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEDI to ERP: automated replenishment\u003c\/li\u003e\n\u003cli\u003eReduces manual orders; 99.5% accuracy\u003c\/li\u003e\n\u003cli\u003e$40B+ routed (2024)\u003c\/li\u003e\n\u003cli\u003e~15% lower fulfilment cost\u003c\/li\u003e\n\u003cli\u003e8-day faster invoice-to-cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthis\u003e\u003c\/pfor\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora's multi-channel logistics: 4,200-vehicle fleet, $40B routed, 58% specialty revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora uses four channels: a 4,200-vehicle direct-delivery fleet (98.4% OTIF, 0.3% loss, 35% faster emergency response), web portals\/EDI\/API for 70%+ retail volume (~$3.5B peak monthly; $40B routed in 2024; 99.5% order accuracy), World Courier for 600,000+ temp-controlled trial shipments (80% ≤48h SLA), and field sales\/educators driving specialty\/services (~58% revenue).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metrics (2024)\u003c\/th\u003e\n\u003cth\u003eImpact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect fleet\u003c\/td\u003e\n\u003ctd\u003e4,200 vehicles; 98.4% OTIF; 0.3% loss\u003c\/td\u003e\n\u003ctd\u003eFaster emergency response -35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeb\/EDI\/API\u003c\/td\u003e\n\u003ctd\u003e70%+ volume; $40B routed; 99.5% accuracy\u003c\/td\u003e\n\u003ctd\u003e-15% fulfilment cost; -8 days cash\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorld Courier\u003c\/td\u003e\n\u003ctd\u003e600k+ shipments; 80% ≤48h SLA\u003c\/td\u003e\n\u003ctd\u003eHandles trials, cold chain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eField sales\u003c\/td\u003e\n\u003ctd\u003eDrives specialty ≈58% revenue\u003c\/td\u003e\n\u003ctd\u003e-15-20% shorter sales cycles\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail Pharmacy Chains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRetail pharmacy chains - including national players like Walgreens Boots Alliance and CVS Health and major regional groups - demand high-volume, same‑day or next‑day delivery across thousands of SKUs; they accounted for roughly 40-55% of Cencora's U.S. distribution volume in 2024 and drove an estimated $20-28 billion in annual sales through Cencora's supply network, valuing competitive pricing and stable inventory turnover.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth Systems and Hospitals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAcute care facilities and large hospital networks depend on Cencora for timely delivery of routine and emergency meds, supporting over 1,500 hospital systems and 6,000 acute sites as of 2025; they require specialized unit-dose packaging and auto-replenishment inventory services that cut stockouts by ~40% and support EBITDA-critical uptime. Their needs are highly complex and demand near-perfect reliability-median fill accuracy \u0026gt;99.9% and same‑day emergency fulfillment capability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical and Biotech Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePharmaceutical and biotech manufacturers buy Cencora's commercialization, clinical-trial support, and third-party logistics services to launch and distribute drugs globally; in 2024 global pharma outsourcing hit about $143B and Cencora's specialty services drove roughly 22% of its $33.8B revenue in 2023, highlighting high-margin growth potential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Physician Practices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora supplies specialty physician practices-oncology, rheumatology, and other clinics-with cold-chain distribution, reimbursement support, and infusion therapies, enabling outpatient care for high-cost biologics and cell therapies; specialty drugs drove ~35% of U.S. drug spend in 2024, underscoring this segment's value. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-margin: specialty drugs ~50-60% gross margins\u003c\/li\u003e\n\u003cli\u003eScale: specialty therapies \u0026gt;$340B global market (2024)\u003c\/li\u003e\n\u003cli\u003eServices: cold chain, hub services, prior authorization\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Public Health Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora supports national stockpiles and distribution for public health programs, handling contracts with US federal and state agencies that demand strict security, audit trails, and surge capacity; during COVID-19 Cencora-managed logistics supported distribution of millions of doses and in 2024 the company reported $3.4B in government-related revenue. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHandles national stockpiles and mass distribution\u003c\/li\u003e\n\u003cli\u003eRequires high security, transparency, auditability\u003c\/li\u003e\n\u003cli\u003eScales fast for health crises-millions of doses moved in 2020-24\u003c\/li\u003e\n\u003cli\u003eReported ~$3.4B government-related revenue in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma Distribution Snapshot: Retail $20-28B, Hospitals 99.9%+, Specialty $340B+\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRetail chains (40-55% vol; $20-28B est. 2024), hospitals (1,500 systems; \u0026gt;99.9% fill accuracy), pharma manufacturers (outsourcing market ~$143B; specialty services 22% of Cencora 2023 revenue $33.8B), specialty practices (specialty drugs ~35% US spend 2024; market \u0026gt;$340B), government ( ~$3.4B revenue 2024; millions doses 2020-24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eKey metrics\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\u003c\/td\u003e\n\u003ctd\u003e40-55% vol; $20-28B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003e1,500 systems; \u0026gt;99.9% accuracy\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturers\u003c\/td\u003e\n\u003ctd\u003e$143B market; 22% revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty\u003c\/td\u003e\n\u003ctd\u003e35% US spend; \u0026gt;$340B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGovernment\u003c\/td\u003e\n\u003ctd\u003e$3.4B; millions doses\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Procurement Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProduct procurement is Cencora's largest expense-buying drugs from manufacturers accounted for roughly 75-80% of cost of goods sold in 2024, driven by high volumes and low margins. Strategic sourcing and vendor negotiations are critical because year‑over‑year drug price swings (examples: generic price volatility ±10-20% in 2023-24) and changing manufacturer terms can swing EBITDA by several hundred million dollars.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and Transportation Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOperating Cencora's global distribution network drives major costs: fuel, vehicle upkeep, and specialized shipping-cold-chain logistics alone can add 20-30% to per-shipment costs for temperature-sensitive pharma, and the company reported ~$2.1B in distribution and logistics expenses in 2024. Routing and load optimization programs target 8-12% cost savings vs. baseline operations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePersonnel and Specialized Labor\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora spends significantly on personnel, from warehouse teams to clinical consultants and pharmacists, with 2024 SG\u0026amp;A showing roughly $1.9B in employee-related costs and average pharmacist pay above $140,000\/year to secure specialized talent; ongoing training and compliance programs add ~3-5% to payroll, reflecting investments to meet evolving US healthcare regulations and complex commercialization demands.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFacility and Technology Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCencora spends heavily on automated distribution centers and a global office network, with property, plant and equipment capex of $1.2 billion in 2024 supporting scale and speed.\u003c\/p\u003e\n\u003cp\u003eOngoing IT and cybersecurity investments-about $220 million in 2024-protect sensitive patient and client data and sustain digital operations across markets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 capex PPE: $1.2B\u003c\/li\u003e\n\u003cli\u003e2024 IT\/cyber spend: $220M\u003c\/li\u003e\n\u003cli\u003eCapital-intensive assets enable high-volume, fast fulfillment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Compliance Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCencora spends material sums on global compliance-audits, quality systems, and legal teams-representing an estimated 3-5% of operating expenses (about $300-500M on a $10B revenue base in 2024) to meet health and safety standards.\u003c\/p\u003e\n\u003cp\u003eIf poorly managed, these costs risk massive fines or license loss; recent industry penalties exceeded $200M in single cases, so proactive spend protects access to markets and revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3-5% of Opex (~$300-500M on $10B revenue, 2024)\u003c\/li\u003e\n\u003cli\u003eCovers audits, QC systems, regulatory legal teams\u003c\/li\u003e\n\u003cli\u003eIndustry fines have topped $200M per case\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e2024 Cost Breakdown: Procurement Dominates COGS; Distribution $2.1B, SG\u0026amp;A $1.9B\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMajor costs: drug procurement (~75-80% of COGS, 2024), distribution\/logistics ~$2.1B (2024), employee-related SG\u0026amp;A ~$1.9B (2024), PPE capex $1.2B (2024), IT\/cyber $220M (2024), compliance 3-5% opex (~$300-500M on $10B revenue, 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement\u003c\/td\u003e\n\u003ctd\u003e75-80% COGS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistribution\u003c\/td\u003e\n\u003ctd\u003e$2.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A (payroll)\u003c\/td\u003e\n\u003ctd\u003e$1.9B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex PPE\u003c\/td\u003e\n\u003ctd\u003e$1.2B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIT\/cyber\u003c\/td\u003e\n\u003ctd\u003e$220M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance\u003c\/td\u003e\n\u003ctd\u003e$300-500M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWholesale Distribution Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe bulk of Cencora's revenue derives from small percentage margins on distributing brand and generic pharmaceuticals; in 2024 Cencora reported $65.8 billion in revenue, with wholesale distribution margins on the high-volume supply chain constituting the largest share. While per-unit margins are low-often 1-3%-the company moves billions of units annually, producing substantial total income and anchoring Cencora's traditional financial model.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Service Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCencora earns higher-margin revenue by charging specialty service fees for commercialization and patient support of complex therapies, often via service contracts rather than per-unit sales; in 2024 these services helped Cencora lift gross margin by ~2.1 percentage points and contributed roughly $1.2 billion of adjusted operating income. This stream is expanding as ~60% of biotech launches in 2023-24 required specialty support, diversifying revenue away from product volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Trial Logistics Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThrough World Courier, Cencora earns premium fees managing end-to-end global clinical trial logistics for biologics and temperature-sensitive materials, a market linked to global pharma R\u0026amp;D spend of about $220B in 2024; World Courier's specialized shipments command higher margins due to cold-chain, regulatory and time-critical requirements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue Added Consulting Fees\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpcencora monetizes its industry expertise by charging strategic consulting and data-analytics fees which in contributed an estimated million non-distribution revenue improving mix boosting consolidated operating margin basis points.\u003e\u003cpthese advisory engagements help partners optimize supply chains and patient access giving cencora higher-margin revenue recurring contract potential.\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 consult rev ~$425M\u003c\/li\u003e\n\u003cli\u003e+80-120 bps operating margin impact\u003c\/li\u003e\n\u003cli\u003eNon-distribution, higher gross margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthese\u003e\u003c\/pcencora\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmacy Solution Subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCencora sells software and services to independent pharmacies via subscriptions and fee-for-service contracts, generating recurring revenue separate from drug margins; in 2024 Cencora reported pharmacy services revenue of $7.1 billion, with digital and network services growing low-double digits year-over-year.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring subscription fees stabilize cash flow\u003c\/li\u003e\n\u003cli\u003eServices connect pharmacies to Cencora network\u003c\/li\u003e\n\u003cli\u003eReduces reliance on drug-margin volatility\u003c\/li\u003e\n\u003cli\u003eScales across ~22,000 U.S. pharmacy locations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCencora 2024: $65.8B Wholesale Core, Specialty \u0026amp; Consulting Fuel Margin Lift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCencora's 2024 revenue mix: $65.8B total with low-margin wholesale distribution (1-3% per unit) driving the bulk, specialty services adding ~$1.2B adjusted operating income and lifting gross margin ~2.1 pts, World Courier premium logistics tied to $220B pharma R\u0026amp;D, consulting ~$425M (+80-120 bps operating margin), and pharmacy services $7.1B recurring.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003e2024 $\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Revenue\u003c\/td\u003e\n\u003ctd\u003e$65.8B\u003c\/td\u003e\n\u003ctd\u003eWholesale-led\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacy Services\u003c\/td\u003e\n\u003ctd\u003e$7.1B\u003c\/td\u003e\n\u003ctd\u003eRecurring, networked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Services\u003c\/td\u003e\n\u003ctd\u003e≈$1.2B adj. OP\u003c\/td\u003e\n\u003ctd\u003eHigher margin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsulting\/Data\u003c\/td\u003e\n\u003ctd\u003e≈$425M\u003c\/td\u003e\n\u003ctd\u003e+80-120 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57354820550987,"sku":"cencora-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/cencora-canvas-business-model.webp?v=1779129646","url":"https:\/\/valuechainanalysis.com\/products\/cencora-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}